NEA Management Company’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

NEA Management Company’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,294,095	Closed	-$1.6M	–	51
2023 Q1	$1.6M	Sell	2,294,095 -698,863	-23%	-$643K	0.11%	41
2022 Q4	$2.69M	Sell	2,992,958 -150,000	-5%	-$435K	0.15%	44
2022 Q3	$18.9M	Hold	3,142,958	–	–	0.94%	28
2022 Q2	$13M	Hold	3,142,958	–	–	0.67%	31
2022 Q1	$11.9M	Hold	3,142,958	–	–	0.35%	39
2021 Q4	$14.1M	Hold	3,142,958	–	–	0.29%	40
2021 Q3	$14.6M	Hold	3,142,958	–	–	0.17%	46
2021 Q2	$22.2M	Buy	3,142,958 +145,276	+5%	+$783K	0.29%	40
2021 Q1	$17.7M	Buy	+2,997,682	New	+$18.2M	0.4%	43

NEA Management Company's STSA Position: Q2 2023 in Review

NEA Management Company sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2023, closing a stake of 2,294,095 shares — an estimated $1.6M sold.

NEA Management Company first reported a position in STSA in Q1 2021 and held it in 9 quarters. The position peaked at $22.2M in Q2 2021. 0 funds tracked by Wall St. Rank hold STSA as of Q2 2023.

NEA Management Company reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
NEA Management Company sold 2,294,095 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $1.6M.
NEA Management Company first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
NEA Management Company's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $22.2M in Q2 2021.
0 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on NEA Management Company's 13F filing for Q2 2023, filed 11 Aug 2023.